IND

Trending Now

Covid 19

Indians suffered worse post Covid lung damage than others, says study; how to improve lung function!

When it comes to lung damage, Covid seems to have taken a heavy toll on the respiratory health of Indians, compared to Europeans and Chinese, says a new study.

Covid lung damage

As per a new study, Indians Covid survivors suffered significant and greater lung function impairment compared to their Europeans and Chinese counterparts. When it comes to lung damage, Covid seems to have taken a heavy toll on the respiratory health of Indians, as demonstrated by this new study. The study done by Christian Medical College, Vellore on the impact of Covid-19 on the functioning of lungs and quality of life in Indians, was published in the PLOS Global Public Health journal

The study was done during the first wave of the pandemic in India on 207 Indians, and shows that the Indian subjects developed worse impairment in lung function compared to other published cohorts mostly with Caucasian subjects. This study was designed to study the impact of post-COVID-19 lung damage in patients who have recovered from Covid-19 infection with the help of lung function testing, exercise tolerance, chest radiography and quality of life measurement

The study added that while most may recover within a year of the infection, others may have permanent lung damage for life. Subjects were made to underwent pulmonary function tests, six-minute walking test, chest radiography, and St. George’s respiratory questionnaire.

“In a large Indian cohort, we have reported the presence of post-Covid-19 residual lung damage, as assessed by lung function tests, exercise capacity, chest radiography and quality of life measurements. Our population reported relatively higher symptomatology and comorbidities and greater lung function impairment, compared to most published studies. We have shown

that post-Covid-19 lung damage results in significant impairment of lung function, quality of life and effort tolerance,” said the study.

In people recovering from COVID-19, there is evidence of potential long-term pulmonary sequelae and associated lung function impairment. The most severe illness in the context of SARS-CoV-2 infection is acute respiratory distress syndrome (ARDS). In some, the ARDS may result in fibrotic interstitial lung disease.

Signs and Symptoms of Post-Covid Lung Damage

Post-Covid lung damage, also known as post-acute sequelae of SARS-CoV-2 infection (PASC) or long COVID, can manifest in various ways, primarily affecting the respiratory system. Individuals recovering from COVID-19 may experience persistent symptoms indicative of lung damage, says Dr Neha Rastogi Consultant, Infectious Diseases, Fortis Memorial Research Institute, Gurugram.

1. Shortness of breath: Difficulty in breathing or shortness of breath, particularly during physical activity, can persist long after the acute phase of the infection has passed.

2. Persistent cough: A lingering cough that lasts for weeks or months after the initial infection is common in individuals with post-Covid lung damage.

3. Chest pain or tightness: Some individuals may experience chest pain or tightness, which can be exacerbated by deep breathing or exertion.

4. Fatigue: Chronic fatigue is a common symptom of post-Covid lung damage, often accompanied by reduced exercise tolerance.

5. Decreased exercise tolerance: Individuals may notice a reduced ability to engage in physical activities they once tolerated, due to persistent shortness of breath or fatigue.

6. Frequent respiratory infections: Vulnerability to respiratory infections may increase following Covid-19, as lung damage can weaken the immune system’s ability to fend off pathogens.

How to treat post-Covid lung damage

Managing post-Covid lung damage involves a multidisciplinary approach aimed at alleviating symptoms and improving lung function, says Dr Rastogi.

Treatment strategies may include:

Pulmonary rehabilitation: Structured exercise programs supervised by healthcare professionals can help improve lung function, endurance, and overall physical health.

Medications: Bronchodilators and anti-inflammatory medications may be prescribed to alleviate symptoms such as shortness of breath and inflammation in the airways.

Oxygen therapy: In cases of severe lung damage, supplemental oxygen therapy may be necessary to ensure adequate oxygen levels in the bloodstream.

Nutritional support: A balanced diet rich in nutrients and hydration is essential for supporting overall health and aiding in recovery.

Psychological support: Dealing with chronic symptoms can take a toll on mental health. Counseling or support groups may be beneficial in coping with the emotional impact of post-Covid lung damage.

Regular monitoring: Close monitoring by healthcare providers is crucial to track progress, adjust treatment plans as needed, and address any emerging complications.

This Article Was Originally Published on Hindustantimes News!

Also Read : Maldives Sitting on a debt pile, not bankrupt as of now!

India Reported 619 cases of JN.1 Variant, According to real-time Updates on Covid cases in India!

India’s COVID-19 Cases Live Updates: According to data released on Friday by the Union Health Ministry, India has seen 761 new cases of COVID-19, while the total number of active cases has decreased to 4,334.

Covid Cases in India: A total of 619 cases of JN.1 variant have been reported from 12 States:

Cases of COVID-19 in India: Twelve new fatalities; five from Kerala, four from Karnataka, two from Maharashtra, and one from Uttar Pradesh were reported. Delhi records 48 active covid-19 cases. a: 761 new cases of Covid-19 along with 12 deaths reported in the past 24 hours.

Covid19 New variant

Covid-19 treatment developer Humanigen files for Chapter 11 bankruptcy!

Drug developer Humanigen has filed for voluntary Chapter 11 bankruptcy, according to a court filing, after struggling to get regulatory approval for its COVID-19 treatment. The Burlingame, California-based company, once controlled by convicted pharma executive Martin Shkreli, listed assets worth $521,000 and total debt of $44.1 million, as per the January 3 filing.

Odisha now has two cases of the Covid-19 sub-variant JN.1, according to a report released on Thursday by the state’s director of health services, Bijay Kumar Mohapatra. Odisha had reported the first case of the JN.1 type on Wednesday. The two cases were identified in Bhubaneswar and Sundargarh; one patient has fully recovered, while the other is undergoing treatment. Samples that tested positive for COVID-19 are undergoing genomic sequencing.

COVID-19 US: With the number of cases of COVID-19 rising to approximately 1,500 each week in the US, medical professionals are looking for explanations for the low uptake of Paxlovid, an extremely effective medication that has been shown to avert serious sickness and death from the virus.

Read Also : The Asus ROG Phone 8 Will Be Release in India On January 9.

Covid19 New variant

Gujarat has 75 active Covid cases. Ahmedabad reported eight new cases—four male and four female—in the twenty-four hours that ended at seven a.m. on Thursday. Among others, Thaltej, Navrangpura, Vejalpur, Paldi, and Chandlodia were among the places where new cases were reported.

Mask mandates return at some US hospitals as COVID, flu jump

Hospitals in at least four US states have reinstated mask mandates amid a rise in cases of COVID, seasonal flu and other respiratory illnesses. Healthcare facilities in New York, California, Illinois and Massachusetts have made masks mandatory among patients and providers. New York City Health Commissioner Dr. Ashwin Vasan told WABC TV on Wednesday that mask mandates had resumed at all 11 of the city’s public hospitals, 30 health centers and five long-term care facilities.

Covid19 masks

High-fat diets found to make immune system changes, enhance risk of Covid Diets high on fat have been found to affect genes linked to the immune system, brain function, and potentially Covid-19 risk in a new study.

India Covid Cases: Two deaths occurred in patients with co-morbidities. In Kerala, a 39-year-old male with chronic obstructive pulmonary disease (COPD) and in Karnataka a 65-year-old male with Hepatocellular Carcinoma, Decompensated Liver Cirrhosis, Portal Vein Thrombosis, diabetes and Chronic Kidney Disease (CKD) succumbed to Covid. A total of 541 cases of JN.1 series variant of Covid-19 have been reported from 12 States till 3rd January.

This article was orginally published on timesofindia news!

Read Also : Revolutionize Your Dental Health: Unveiling the Superfoods for a Radiant Smiles.